Zyryanov S.K. - list of publications

AGE PECULIARITIES OF PHARMACOTHERAPY WITH AMOXICILLIN PREPARATIONS IN CHILDREN WITH CYSTIC FIBROSIS

Article

Kondratieva E.I., Kondakova Y.A., Zyryanov S.K., Bondareva I.B., Voronkova A.Y., Sherman V.D., Melyanovskaya Y.L., Odinayeva N.D., Dronov I.A.

Pediatriya - Zhurnal im G.N. Speranskogo. Vol. 98. 2019. P. 179-188

CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH

Article

Tolkushin A.G., Zyryanov S.K., Pogudina N.L., Davydovskaya M.V.

Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. Vol. 11. 2019. P. 48-60

MEDICATION ERRORS ASSOCIATED WITH BETA-LACTAM ANTIBIOTICS: ANALYSIS OF RUSSIAN SPONTANEOUS REPORTING DATABASE

Article

Kuzmina A.V., Asetskaya I.L., Polivanov V.A., Zyryanov S.K.

Antibiotiki i Khimioterapiya. Vol. 64. 2019. P. 48-53

ЭКОНОМИЧЕСКАЯ ЦЕЛЕСООБРАЗНОСТЬ ПРИМЕНЕНИЯ ИММУНОБИОЛОГИЧЕСКОГО ПРЕПАРАТА ОМАЛИЗУМАБ У ПАЦИЕНТОВ С ТЯЖЕЛОЙ БРОНХИАЛЬНОЙ АСТМОЙ В УСЛОВИЯХ ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ

Article

Зырянов С.К., Белевский А.С., Дьяков И.Н.

Астма и аллергия. 2019. P. 28-37

ABDOMINAL INFECTION. ANALYSIS, COMPARISON AND APPROACHES TO ANTIBIOTIC THERAPY: RUSSIAN AND INTERNATIONAL EXPERIENCE AND RECOMMENDATIONS

Article

Rodoman G.V., Zyryanov S.K., Romashov O.M., Ivzhits M.A., Putsman G.A., Ionidi P.V., Kosenko O.A., Chenkurov M.S.

Хирург. 2019. P. 45-59

GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE [ПРОБЛЕМЫ ГЕРИАТРИИ В КАРДИОЛОГИЧЕСКОЙ ПРАКТИКЕ]

Article

Tkacheva O.N., Belenkov Yu.N., Karpov Yu.A., Zyryanov S.K.

Kardiologiia. KlinMed Consulting. Vol. 59. 2019. P. 54-63

PHARMACOECONOMIC ANALYSIS OF USING BIOLOGICAL AGENTS FOR UNCONTROLLED MODERATE-TO-SEVERE ATOPIC ASTHMA IN THE RUSSIAN FEDERATION

Article

Zyryanov S.K., Diyakov I.N., Avdeev S.N.

Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. Vol. 12. 2019. P. 268-278

MURAMYLDIPEPTIDE-BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE [СОЕДИНЕНИЯ НА ОСНОВЕ МУРАМИЛПЕПТИДОВ В СОВРЕМЕННОЙ МЕДИЦИНЕ: ФОКУС НА ГЛЮКОЗАМИНИЛМУРАМИЛДИПЕПТИД]

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Terapevticheskii Arkhiv. Vol. 91. 2019. P. 122-128

COMPARATIVE PHARMACOECONOMICS OF BX IN THE TREATMENT OF PATIENTS WITH UNCONTROLLED MODERATE AND SEVERE ATOPIC ASTHMA IN THE RUSSIAN HEALTH CARE SETTING

Article

Zyryanov S., Dyakov I.

Value in Health. Vol. 22. 2019.

PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG ELDERLY PATIENTS IN CLINICAL PRACTICE

Article

Al-Rajavi A., Zyryanov S.K., Ushkalova E.A., Butranova O.I., Pereverzev A.P.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 57-65

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 23-32

MODERN APPROACHES TO THE RATIONAL CHOICE OF ANTIBIOTIC FOR TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN VARIOUS CATEGORIES OF PATIENTS

Article

Zyryanov S.K., Butranova O.I.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 89-105

CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER: INDIVIDUAL THERAPY AND ITS PATHOGENETIC BACKGROUND

Article

Bobrova O.P., Shnayder N.A., Dychno Y.A., Zyryanov S.K., Petrova M.M.

Russian Open Medical Journal. Russian Open Medical Journal. Vol. 8. 2019.

SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE

Article

Shmaevskij P.E., Kosyakina N., Cigura D.A., Zatolochina K.E., Zyryanov S.K., Asetskaya I.L., Kazakov A.S.

SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. Российский университет дружбы народов (РУДН). 2019. 142 p.

ECONOMIC PERSPECTIVES FOR EFFECTIVE CONTROL OF DIABETES MELLITUS TYPE 2 WITH FIXED COMBINATION OF BASAL INSULIN ANALOG AND GLP-1 AGONIST

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 4-14

CLINICAL AND ECONOMIC ANALYSIS OF THE AXITINIB AS A SECOND-LINE TARGET THERAPY FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

Article

Zyrianov S.K., Diakov I.N.

Медицинские технологии. Оценка и выбор. Фонд развития социальной политики и здравоохранения Гелиос. Vol. 36. 2019. P. 59-68

QUANTIATIVE ANA QUALITATIVE ASSESSMENT OF THE RANGE OF ANTIASTHMA MEDICINES AVAILABLE TO RUSSIAN CONSUMERS

Article

Ivanov D.A., Kubaeva M.B., Zyryanov S.K.

Фармакоэкономика: теория и практика. Vol. 7. 2019. P. 38-39

MODELING OF THE IMPACT OF BIOLOGICAL DRUGS IN THE ECONOMIC BURDEN OF SEVERE ASTHMA

Article

Zyryanov Sergey, Dyakov Ilya, Karpov Oleg

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 4-12

MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Terapevticheskii Arkhiv. Vol. 91. 2019. P. 122-127

THE EFFECT OF OPRM1, ABCB1, IL1B, PTGS2, LOC 541472 GENE POLYMORPHISM ON THE VARIABILITY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER

Article

Bobrova Olga, Schnider Natalya, Zyryanov Sergey, Dmitrenko Diana, Zobova Svetlana, Zukov Ruslan

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 53-59

DISCREPANCIES IN DRUG LABELING TEXTS AS A CAUSE OF MEDICATION ERRORS

Article

Kuzmina A.V., Asetskaya I.L., Polivanov V.A., Zyryanov S.K., Glagolev S.V.

Вестник Росздравнадзора. Федеральное государственное бюджетное учреждение Информационно-методический центр по экспертизе, учету и анализу обращения средств медицинского применения Росздравнадзора. 2019. P. 59-62

DRUG ADJUSTMENT OF MODIFIED RISK FACTORS AS ONE OF THE LEADING STRATEGIES FOR MANAGING PATIENTS WITH CARDIOVASCULAR DISEASES

Article

Zyryanov S.K., Baybulatova E.A.

Медицинский совет. ООО «ГРУППА РЕМЕДИУМ». 2019. P. 22-38

GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION?

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Ima-Press Publishing House. Vol. 10. 2018. P. 75-80

PHARMACOECONOMIC ANALYSIS OF AFATINIB AND GEFITINIB FOR THE TREATMENT OF LUNG CANCER

Article

Fedyayev D.V., Zyryanov S.K.

Медицинские технологии. Оценка и выбор. Фонд развития социальной политики и здравоохранения Гелиос. 2018. P. 68-84

PHARMACOECONOMIC ASSESSMENT OF DUAL BRONCHODILATION THERAPY IN PATIENTS WITH COPD

Article

Zyryanov S.K., D'yakov I.N.

Pulmonologiya. Medical Education. Vol. 28. 2018. P. 61-68

Зырянов С.К.

List of records

AGE PECULIARITIES OF PHARMACOTHERAPY WITH AMOXICILLIN PREPARATIONS IN CHILDREN WITH CYSTIC FIBROSIS

CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH

MEDICATION ERRORS ASSOCIATED WITH BETA-LACTAM ANTIBIOTICS: ANALYSIS OF RUSSIAN SPONTANEOUS REPORTING DATABASE

ABDOMINAL INFECTION. ANALYSIS, COMPARISON AND APPROACHES TO ANTIBIOTIC THERAPY: RUSSIAN AND INTERNATIONAL EXPERIENCE AND RECOMMENDATIONS

GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE [ПРОБЛЕМЫ ГЕРИАТРИИ В КАРДИОЛОГИЧЕСКОЙ ПРАКТИКЕ]

PHARMACOECONOMIC ANALYSIS OF USING BIOLOGICAL AGENTS FOR UNCONTROLLED MODERATE-TO-SEVERE ATOPIC ASTHMA IN THE RUSSIAN FEDERATION

MURAMYLDIPEPTIDE-BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE [СОЕДИНЕНИЯ НА ОСНОВЕ МУРАМИЛПЕПТИДОВ В СОВРЕМЕННОЙ МЕДИЦИНЕ: ФОКУС НА ГЛЮКОЗАМИНИЛМУРАМИЛДИПЕПТИД]

COMPARATIVE PHARMACOECONOMICS OF BX IN THE TREATMENT OF PATIENTS WITH UNCONTROLLED MODERATE AND SEVERE ATOPIC ASTHMA IN THE RUSSIAN HEALTH CARE SETTING

PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG ELDERLY PATIENTS IN CLINICAL PRACTICE

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS

MODERN APPROACHES TO THE RATIONAL CHOICE OF ANTIBIOTIC FOR TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN VARIOUS CATEGORIES OF PATIENTS

CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER: INDIVIDUAL THERAPY AND ITS PATHOGENETIC BACKGROUND

SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE

ECONOMIC PERSPECTIVES FOR EFFECTIVE CONTROL OF DIABETES MELLITUS TYPE 2 WITH FIXED COMBINATION OF BASAL INSULIN ANALOG AND GLP-1 AGONIST

CLINICAL AND ECONOMIC ANALYSIS OF THE AXITINIB AS A SECOND-LINE TARGET THERAPY FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

QUANTIATIVE ANA QUALITATIVE ASSESSMENT OF THE RANGE OF ANTIASTHMA MEDICINES AVAILABLE TO RUSSIAN CONSUMERS

MODELING OF THE IMPACT OF BIOLOGICAL DRUGS IN THE ECONOMIC BURDEN OF SEVERE ASTHMA

MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE

THE EFFECT OF OPRM1, ABCB1, IL1B, PTGS2, LOC 541472 GENE POLYMORPHISM ON THE VARIABILITY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER

DISCREPANCIES IN DRUG LABELING TEXTS AS A CAUSE OF MEDICATION ERRORS

DRUG ADJUSTMENT OF MODIFIED RISK FACTORS AS ONE OF THE LEADING STRATEGIES FOR MANAGING PATIENTS WITH CARDIOVASCULAR DISEASES

GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION?

PHARMACOECONOMIC ANALYSIS OF AFATINIB AND GEFITINIB FOR THE TREATMENT OF LUNG CANCER

PHARMACOECONOMIC ASSESSMENT OF DUAL BRONCHODILATION THERAPY IN PATIENTS WITH COPD

Other authors

Velibekov M.C.

Gorbatenko R.G.